ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.098,09
-0,50%
S&P 500
5.277,51
0,80%
US Dollar vs BRL
5,2463
0,00%
Bitcoin
67.760,10
0,05%
Brent Oil
81,295
0,00%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Abraxis Bioscience (MM) (ABBI)

  7. Abraxis Bioscience (MM) (ABBI) Notícias

ABBI

Abraxis Bioscience (MM) (ABBI)

Abraxis Bioscience (MM)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ABBI
DataHoraFonteTítuloCódigoCompanhia
12/11/200812:00PR Newswire (US)Deloitte Names Abraxis BioScience Inc. Fastest Growing Technology Company in Los Angeles AreaNASDAQ:ABBIAbraxis Bioscience (MM)
12/11/200811:00PR Newswire (US)Deloitte Unveils 2008 Technology Fast 500 RankingNASDAQ:ABBIAbraxis Bioscience (MM)
13/11/200720:02Edgar (US Regulatory)Abraxis Bioscience, Inc. (Other) (S-8 POS)NASDAQ:ABBIAbraxis Bioscience (MM)
13/11/200719:55Edgar (US Regulatory)Abraxis Bioscience, Inc. (Other) (POSASR)NASDAQ:ABBIAbraxis Bioscience (MM)
13/11/200714:19Edgar (US Regulatory)Abraxis Bioscience, Inc. (Other) (8-K)NASDAQ:ABBIAbraxis Bioscience (MM)
08/11/200714:03Edgar (US Regulatory)Abraxis Bioscience, Inc. - Current report filing (8-K)NASDAQ:ABBIAbraxis Bioscience (MM)
05/11/200719:58Edgar (US Regulatory)Abraxis Bioscience, Inc. - Prospectus filed pursuant to Rule 424(b)(7) (424B7)NASDAQ:ABBIAbraxis Bioscience (MM)
30/10/200718:23Edgar (US Regulatory)Abraxis Bioscience, Inc. - Statement of Changes in Beneficial Ownership (4)NASDAQ:ABBIAbraxis Bioscience (MM)
30/10/200718:22Edgar (US Regulatory)Abraxis Bioscience, Inc. - Amended Statement of Changes in Beneficial Ownership (4/A)NASDAQ:ABBIAbraxis Bioscience (MM)
10/08/200709:05Business WireAPP Receives Expedited Approval for the First and Only Generic Cefotetan Disodium for InjectionNASDAQ:ABBIAbraxis Bioscience (MM)
09/08/200721:50Business WireAbraxis BioScience Files Information Statement in Connection with Its Announced Separation into Two Publicly Traded CompaniesNASDAQ:ABBIAbraxis Bioscience (MM)
09/08/200709:05Business WireAbraxis BioScience Reports Second Quarter 2007 Revenue of $243 Million versus $161 Million in Prior Year PeriodNASDAQ:ABBIAbraxis Bioscience (MM)
08/08/200723:35Business WireAbraxis BioScience Announces Licensing Agreement with Biocon Limited for the Commercialization of ABRAXANE in IndiaNASDAQ:ABBIAbraxis Bioscience (MM)
08/08/200719:20Business WireAbraxis BioScience Launches Doxorubicin Hydrochloride Injection, USPNASDAQ:ABBIAbraxis Bioscience (MM)
07/08/200709:00Business WireAbraxis BioScience Receives FDA Approval for Oxytocin Injection 10 USP Units/mL in a 30 mL VialNASDAQ:ABBIAbraxis Bioscience (MM)
06/08/200717:15Business WireAbraxis BioScience Receives Final Approval for Fosphenytoin Sodium Injection, USPNASDAQ:ABBIAbraxis Bioscience (MM)
06/08/200709:00Business WireAbraxis BioScience Acquires from the Buck Institute Exclusive Worldwide Intellectual Property Rights for Technologies Designed tNASDAQ:ABBIAbraxis Bioscience (MM)
02/08/200719:55Business WireAbraxis BioScience Receives FDA Approval for Caffeine Citrate Injection USP, 20 mg/mLNASDAQ:ABBIAbraxis Bioscience (MM)
31/07/200717:45Business WireAbraxis BioScience Acquires Manufacturing Facility from WatsonNASDAQ:ABBIAbraxis Bioscience (MM)
26/07/200709:00Business WireAbraxis BioScience and the California NanoSystems Institute Announce Partnership for Collaborative Research in the Development oNASDAQ:ABBIAbraxis Bioscience (MM)
19/07/200717:05Business WireAbraxis BioScience and Biocon Limited Announce Licensing Agreement for G-CSF in North America and the European UnionNASDAQ:ABBIAbraxis Bioscience (MM)
16/07/200717:05Business WireAbraxis BioScience Announces Date for Second Quarter Financial Results and Investor Conference CallNASDAQ:ABBIAbraxis Bioscience (MM)
02/07/200708:05Business WireAbraxis BioScience Announces Plan to Separate Into Two Independent Public CompaniesNASDAQ:ABBIAbraxis Bioscience (MM)
19/06/200709:00Business WireAbraxis BioScience Exclusively Licenses Intellectual Property Portfolio Designed to Personalize Treatment for Colorectal CancerNASDAQ:ABBIAbraxis Bioscience (MM)
07/06/200709:00Business WireAbraxis BioScience to Present at the Goldman Sachs 28th Annual Global Healthcare ConferenceNASDAQ:ABBIAbraxis Bioscience (MM)
04/06/200722:33PR Newswire (US)New Data Shows Promising Antitumor Activity with nab-paclitaxel (ABRAXANE(R)) in Combination and as a Single Agent for the TreatNASDAQ:ABBIAbraxis Bioscience (MM)
02/06/200710:05Business WireABRAXANE Demonstrates Longer Progression-Free Survival versus Taxotere in the Treatment of First-Line Metastatic Breast CancerNASDAQ:ABBIAbraxis Bioscience (MM)
30/05/200709:05Business WireNew Data Highlighting ABRAXANE as Single Agent and in Combination for the Treatment of Breast, Lung and Ovarian Cancers to Be PrNASDAQ:ABBIAbraxis Bioscience (MM)
23/05/200709:00Business WireAbraxis BioScience to Present at the Bank of America 2007 Health Care ConferenceNASDAQ:ABBIAbraxis Bioscience (MM)
14/05/200717:05Business WireAbraxis BioScience Founder Awarded Ellis Island Medal of HonorNASDAQ:ABBIAbraxis Bioscience (MM)
 Apresentando as notícias mais relevantes sobre:NASDAQ:ABBI

Seu Histórico Recente

DBI
DAX
DAX
COIN
EOSBTC
EOS
BOV
ELET3
ELETROBRAS ON
BOV
BBAS3
BANCO DO BRASIL ON
BOV
PETR4
PETROBRAS PN
BOV
GGBR4
GERDAU PN
COIN
BCHBTC
Bitcoin Cash
BOV
ITSA4
ITAUSA PN
BOV
USIM5
USIMINAS PNA
COIN
PLUS1BTC
PlusOneCoin
COIN
BTCUSD
Bitcoin
COIN
XLMBTC
Stellar Lumens
BOV
VALE3
VALE ON
COIN
XRPBTC
Ripple
NYSE
PBR
Petroleo Brasileiro ADR
COIN
DASHUSD
Dash
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados